Marieta Branis
Adult Health · Hackensack, NJNPI 1285849885
Payments from drug & device makers
Across 211 payments — averaging $12.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$655
- Daiichi Sankyo Inc.$572
- AstraZeneca$396
- Seagen Inc.$188
- Eisai Inc.$153
- Merck$139
- plus $552 from 13 others
What the payments were for
- Food & beverage$2,57697%
- Education$803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 66 | $655 |
| Daiichi Sankyo Inc. | 63 | $572 |
| AstraZeneca | 23 | $396 |
| Seagen Inc. | 8 | $188 |
| Eisai Inc. | 9 | $153 |
| Merck | 9 | $139 |
| AbbVie | 8 | $128 |
| Stemline Therapeutics Inc. | 5 | $91 |
| Lilly USA, LLC | 4 | $63 |
| GSK | 3 | $52 |
| Taiho Oncology, Inc. | 3 | $52 |
| Pfizer | 2 | $38 |
| Johnson & Johnson | 2 | $32 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| Beone Medicines USA, Inc. | 1 | $18 |
| Foundation Medicine, Inc. | 1 | $16 |
| CTI Biopharma Corp. | 1 | $15 |
| Immunogen, Inc. | 1 | $14 |
| Clovis Oncology, Inc. | 1 | $13 |
How this compares
$2,656 in reported general payments places this provider in the 85th percentile of 1,135 adult health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VerzenioAbemaciclib | 18 | $261,377 |
| EliquisApixaban | 14 | $14,822 |
| Exemestane | 12 | $2,969 |
| Anastrozole | 76 | $1,772 |
| Letrozole | 22 | $776 |
| Ondansetron Hcl | 18 | $106 |
| Prochlorperazine Maleate | 11 | $74 |
| Gabapentin | 14 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCVerzenio | $63 | $261,37718 claims |
| PfizerEliquis | $38 | $14,82214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,135 adult health providers in New Jersey.
Other adult health in Hackensack
- June HalperHackensack$458K
- Phyllis McKiernanHackensack$72K
- Samantha DepadovaHackensack$34K
- Pamela SutherlandHackensack$22K
- Rosemarie WellmanHackensack$9K
- Derrick RodriguezHackensack$8K
- Susan KumkaHackensack$8K
- Caroline KozekHackensack$7K
- Rey PellaHackensack$6K
- Kara SaggiomoCamden$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.